Ancient Viral DNA May Hold Key to Brain Degeneration, Study Finds

IO_AdminUncategorized1 week ago18 Views

Quick Summary:

  • Finding by Renée Douville (2008): Found virus-like proteins in brains of ALS patients without evidence of active viral infections; ancient viral genes on chromosomes had reawakened.
  • Jumping Genes and Retrotransposons: about 40% of the human genome consists of retrotransposons, “jumping genes” that copy themselves via RNA intermediates.Most are dormant but can reawaken, causing inflammation and nerve cell damage linked to diseases like Alzheimer’s and ALS.
  • TDP-43 protein Role: TDP-43 regulates jumping genes in the nucleus but forms toxic clumps in neurodegenerative conditions like ALS. Its dysfunction leads to retrotransposon activation and brain degeneration.
  • Tau protein Connection: Tau protein defects destabilize DNA structures suppressing jumping genes, fueling neurodegeneration associated with Alzheimer’s disease.
  • Antiretroviral Trials for Neurodegeneration: Drugs borrowed from HIV treatment have shown early promise in clinical trials for ALS and Alzheimer’s patients by reducing retroviral gene activity.

!Illustration
Image credit: Knowable Magazine/CC BY-ND

!Pie Chart Portrayal
Image credit: Knowable Magazine/CC BY-ND

!Infographic on Jumping Genes Mechanism
Image credit: Knowable Magazine/CC BY-ND

Indian Opinion Analysis:

The exploration into reawakened viral elements could redefine our understanding of neurological disorders such as ALS and alzheimer’s-diseases previously attributed solely to genetic or environmental causes.For India, where population aging is projected to escalate cases of such conditions, these findings have scientific relevance. Advances emphasizing antiviral therapies derived from HIV research offer potential cost-effective treatments that could be scaled even for resource-constrained settings.

India’s healthcare ecosystem stands at a critical juncture; clinical trials abroad pave pathways toward collaborative research opportunities linking genomics with therapeutic innovation hear. while promising, caution remains due to complexity in mechanisms-retrotransposons may only explain a subset of cases. Strengthening healthcare R&D will allow india to contribute globally while addressing its domestic burden.

Read More

0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Leave a reply

Recent Comments

No comments to show.

Stay Informed With the Latest & Most Important News

I consent to receive newsletter via email. For further information, please review our Privacy Policy

Advertisement

Loading Next Post...
Follow
Sign In/Sign Up Sidebar Search Trending 0 Cart
Popular Now
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...

Cart
Cart updating

ShopYour cart is currently is empty. You could visit our shop and start shopping.